| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |